This formulation is intended strictly for laboratory research use and is supplied in a standardized, lyophilized format to support reproducibility and consistency across experimental workflows
By establishing a $50 monthly copay, the program seeks to reduce financial barriers and ensure more equitable access
For more information on diabetes management and GLP-1 receptor agonists, the Diabetes Australia provides extensive resources at References Drucker, D
Some types of MBS, such as BPD and SADI, although very effective, should be used with caution because of safety issues, whereas RYGB and LSG combine good efficacy with greater safety
Portincasa P, Ciaula AD, Bonfrate L, Wang DQ